AKT1 and neoplasm: For example, the activation of PI3K/AKT/mTOR and other carcinogenic pathways is related to the changes of bioenergy pathways such as glycolysis, fatty acid and glutamine metabolism, which provides a new target for tumour therapy.25, 26, 27